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lateral vessels between the right and left coronary sys-
tems. The mechanism to explain the clinical presenta-
tion was proposed by Edwards,2 who emphasized the
dynamic nature of the pathophysiologic condition.
Inadequate collateral flow results in left ventricular
(LV) infarction, ranging from subendocardial to trans-
mural in extent but often patchy in distribution, and
causes ischemic damage to the papillary muscles,
resulting in mitral regurgitation.
Several surgical procedures have been described, ini-
tially palliative, but more recently restoring a 2-coro-
nary system, including various forms of bypass graft
from the aorta,3,4 subclavian artery anastomosis,5 intra-
pulmonary bypass graft,6 intrapulmonary baffle,7 and
direct coronary translocation to the aorta.8-10
We reviewed our experience between 1980 and 1998
with this defect, the late clinical results, and the time-
course of recovery of LV function. In addition, the con-
A nomalous origin of the left coronary artery from thepulmonary artery (ALCAPA) is an uncommon con-
genital defect that is often lethal if not diagnosed and
treated.1 The pathophysiologic condition depends on
the pressure difference between the systemic and pul-
monary arterial circulations and on the adequacy of col-
Objective: The aim of this study was to review the results of operations for
anomalous left coronary artery from the pulmonary artery and the late
outcome for exercise capacity, left ventricular function, and mitral
regurgitation. Methods: Twenty-one patients underwent operations over
an 18-year period (median age, 9 months; range, 6 weeks–26 years) with
a median follow-up of 6.5 years (range, 2 months–18 years). In addition
to clinical and echocardiographic follow-up, patients at our institution
were also investigated with radionuclide scans (n = 10) and treadmill
exercise testing (n = 8). Results: There were no operative or late deaths
(0%; 95% confidence interval [CI], 0% and 16%). Five patients
required support with a left ventricular assist device. Eighteen patients
are currently in New York Heart Association class I, and 3 patients are
mildly symptomatic. On nuclear gated scan at a mean of 6 years after
the operation, the left ventricular ejection fraction was 64% (SD, 3%) at
rest and increased to 74% (SD = 3%) on exercise (95% CI for the dif-
ference, 6%, 14%; P = .001). Treadmill endurance was normal for age
(9.8-14.5 minutes) in those old enough to exercise. On echocardiography
(n = 18), the current fractional shortening was 34% (SD, 4%) in the 15
patients with normal or only mildly abnormal ventricular septal motion.
Three patients have undergone mitral valve operations. The left ven-
tricular end-diastolic dimension fell from 48 mm (SD, 5.8 mm) before
surgery to 35.1 mm (SD, 5.2 mm) at 1 year after the operation, and the
fractional shortening increased over the first year from 19.6% (SD,
9.3%) to 32.8% (SD, 5.9%; both P < .001). Conclusions: Long-term clin-
ical outcome and left ventricular function are good, despite severe left
ventricular dysfunction at presentation. (J Thorac Cardiovasc Surg
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dition of all patients available for detailed review at our
institution was investigated to assess global and region-
al LV function, mitral regurgitation, and exercise
capacity.
Patients and methods
From January 1980 to March 1998, 21 patients underwent
an operation for ALCAPA. The records were reviewed to doc-
ument the clinical features, operative procedures, and the
perioperative course.
All 10 patients living in the state of Victoria underwent
clinical review at the hospital, and the cases were reinvesti-
gated. The clinical status of the other patients was reviewed
by contact with the treating cardiologists, and the reports of
the most recent echocardiograms were obtained. Clinical fol-
low-up was achieved on all patients.
Patient sample. Among the 21 infants and children, there
were 13 female patients and 8 male patients. The median age
at examination and operation was 9 months (range, 6
weeks–26 years); 13 of the 21 patients were less than 12
months of age.
Fourteen patients who experienced heart failure and severe
LV impairment had a younger median age of 5 months
(range, 6 weeks–22 months). Five patients had a murmur of
mitral regurgitation and impaired LV function, without evi-
dence of heart failure, at a median age of 2 years (range, 9
months–5 years). Two patients experienced chest pain at 11
and 26 years of age; the younger patient had undergone liga-
tion of the left main coronary artery in infancy.
Mitral regurgitation was present in 19 patients at the time
of diagnosis (severe in 5 patients, moderate in 10 patients,
and mild in 4 patients). One other patient had undergone
mitral valve replacement (23-mm mechanical valve) at 10
months of age, before the diagnosis of ALCAPA was made
15 months later. The anomalous coronary artery was not
diagnosed until the persistently impaired LV function after
the valve operation led to reinvestigation.
One infant who experienced severe heart failure, mitral
regurgitation, and pericardial effusion on echocardiography
was found to have a bloody effusion with an incipient rupture
of the anterior LV wall because of transmural infarction.
Extensive infarct resection and LV repair were performed
with aortic implantation of the coronary artery.
Early in this experience in one other infant, the diagnosis of
ALCAPA was missed until postmortem. She was examined at
7 weeks of age with severe heart failure, and a diagnosis of
idiopathic dilated cardiomyopathy was made. She improved
very little on medical therapy until death at 8 months of age.
In all other patients, an operation was performed within hours
to days of the diagnosis of the anomalous coronary artery.
Seventeen of 21 patients had angiography before surgical
repair (Fig 1). In the other patients, the diagnosis was clear on
Fig 1. Preoperative aortogram. A, The figure demonstrates a dilated right coronary artery; no left coronary artery
is seen. B, The figure shows late filling of the left coronary artery and passage of contrast into the MPA.
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echocardiography. No infant was refused an operation be-
cause of poor LV function.
Two children have undergone valve replacement (one
before the recognition of the coronary lesion), and one other
child underwent concomitant mitral valve repair because
there was severe regurgitation and the child was almost 2
years of age.
Coronary artery anatomy. In 20 patients, the whole left
main coronary artery was involved. In one infant, who expe-
rienced heart failure and mitral regurgitation, the circumflex
coronary artery alone arose from the main pulmonary artery
(MPA). The circumflex artery was subsequently shown to be
“dominant” and supplied the posterior descending artery.
In 18 patients, the anomalous artery arose from the MPA,
in 2 patients at the origin of the right pulmonary artery and in
one patient from the mid–right pulmonary artery.
Surgical procedures. The 2 common forms of repair used
were the intrapulmonary baffle (Takeuchi repair, n = 12) and
direct aortic implantation (n = 7), with increasing use of aor-
tic implantation in the latter half of the series.
Direct implantation was performed by mobilization of a
large button of pulmonary artery wall around the anomalous
coronary ostium, often removing the whole of the sinus, and
creation of a trap-door flap in the aorta. The technique of
coronary prolongation described by Sese and Imoto11 was
used in 2 patients, creating an inferior aortic wall flap and a
superior pulmonary arterial flap. The pulmonary sinus was
repaired with autologous pericardium (Fig 2).
One 11-year-old patient, who had undergone coronary li-
gation in infancy, was examined again in 1983 with possible
angina; a saphenous vein bypass graft was the choice of ther-
apy at the time because the ostium had been obliterated.
The infant with the anomalous circumflex coronary artery
underwent ligation of the circumflex artery by a left thora-
cotomy, in the belief that the myocardial insult from a cir-
cumflex artery lesion was likely to be limited and because the
patient was quite small (2.3 kg). However, the infant required
nasogastric-tube feeding for many months and continued
medical therapy for heart failure with mitral regurgitation.
Investigational subgroup. A subgroup of 10 infants and
children were recently reviewed in our institution and inves-
tigated further with transthoracic echocardiography, a
radionuclide scan, and a treadmill exercise test. The median
age at review was 7.2 years (range, 13 months–16.9 years),
with 7 female patients and 3 male patients. The median time
from the operation was 6.5 years (range, 9 months–16.7
years). The procedures included intrapulmonary baffle repair
(n = 5), aortic implantation (n = 4), and ligation of an anom-
alous circumflex artery (n = l). Three patients had required
postoperative support with an LV assist device (LVAD).
Nine of the 10 patients were completely asymptomatic, in
New York Heart Association (NYHA) class I, although the
child who had undergone circumflex ligation had persisting
exertional dyspnea. Two patients received angiotensin-con-
verting enzyme inhibitors. One patient had undergone mitral
valve replacement subsequent to the primary repair; 6 of the
other 9 patients had residual murmurs of mitral regurgitation.
The investigational group is compared with the other patients
in Table I. There is no difference between the groups except
for the fractional shortening percent on echocardiography
before surgery, which was significantly worse in the investi-
gational group. This excludes any selection bias between the
2 groups.
Echocardiographic assessment. The most recent echocar-
diographic results were available for 18 patients (median age
at echocardiography, 7.2 years; interquartile range, 4.2-12.5
Fig 2. Operative technique for aortic implantation. This fig-
ure demonstrates completion of the coronary artery transfer
and patch repair of the pulmonary artery sinus. (From Buxton
B, Frazier OH, Westaby S, editors. Ischemic heart disease:
surgical management. London: Mosby-Wolfe, 1998. By per-
mission of Mosby International, Ltd.)
Table I. Comparison of the investigational group with
patients followed up at other institutions
Investigational 
group Others 
(n = 10) (n = 11) P value
Age at surgery (mo; median) 4.7 10.5 .14
Sex (M:F) 3:7 5:6 >.20
Fractional shortening % 15 23 .03
at presentation (median)
LVAD support 3 2 >.20
Fractional shortening on 33 35 >.20
most recent study (%; median)
Follow-up time (y; median) 6.5 5.2 >.20
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years; median body surface area, 0.93 m2; interquartile range,
0.68-1.36 m2). The median postoperative time to study was 5
years (interquartile range, 15 months–9.3 years).
Transthoracic 2-dimensional, M-mode, and color Doppler
echocardiography was performed on all patients. Ten patients
were studied at our institution, and the studies were reviewed
by one of the authors (D.M.C.). For the other 8 patients, who
lived outside of Victoria, the latest echocardiography result
was obtained from their cardiologists. The findings assessed
were the LV end-diastolic dimension (LVEDD) with respect to
body surface area,12 LV shortening fraction corrected for
age,13 ventricular septal motion, and the presence and degree
of mitral regurgitation. The shortening fraction was not taken
into account in patients with flat or paradoxic ventricular sep-
tal motion. Mitral regurgitation was graded by color flow
Doppler mapping as absent, trivial to mild, moderate, or
severe according to a combination of the width of the regurgi-
tant jet at the mitral valve orifice and the extent of the jet into
the left atrium. In patients who had undergone an intrapul-
monary baffle repair, the presence of any baffle leak and/or
increased peak systolic flow velocity in the MPA was noted.
To assess the time course of change in LV fractional short-
ening and LVEDD after the time of operation, all recorded
measurements were grouped into 5 time periods (preopera-
tive, 1 week after the operation, 1 to 6 months, 9 to 18
months, and more than 2 years from the operation).
Exercise testing. A treadmill test was performed in 8 chil-
dren, all of whom were over 5 years of age and cooperative.
Two children were too young to perform the test. Resting 12-
lead electrocardiography was performed, followed by a Bruce
exercise protocol.14 Continuous electrocardiographic moni-
toring was performed throughout the exercise test and until 6
minutes after the completion of the test. The blood pressure
change was measured at peak exercise, and the duration of
exercise was recorded. Exercise duration and peak heart rates
were compared with pediatric normal values.15 Cardio-
pulmonary testing was not performed.
Radionuclide cardiac studies. Gated nuclear scans were
performed in all 10 patients, and exercise was possible in 7
patients. The first-pass right ventricular ejection fraction was
measured in the right anterior oblique projection. The LV
ejection fraction (LVEF) was measured in the left anterior
oblique projection at rest and during graded semisupine bicy-
cle exercise.
Statistical methods. The confidence limits for death were
determined by the binomial exact technique; the 1-sided
97.5% confidence limit was used because there were no
deaths. Freedom from reoperation was analyzed by the
Kaplan-Meier method. The radionuclide ejection fractions
before and after exercise were compared by paired t test.
Longitudinal changes over time in LV fractional shortening
and LVEDD were compared by linear regression, with stan-
dard errors calculated from the information sandwich formula
for repeated measurements within individual patients.16 Data
were not available on each patient in every time period, but all
available data were included in the analysis. This involves an
assumption that data were missing at random, which was
checked by repeating the analysis for fully observed patients
only to ensure that the conclusions did not change.
Statistical calculations were performed with Stata
Statistical Software (release 5.0; Stata Corp, College Station,
Texas). Results are expressed as the mean and standard devi-
ation for normally distributed data and as the median, range,
and interquartile range for skewed data.
Results
Early and late clinical status. There were no peri-
operative or 30-day deaths (0%; 95% CI, 0% and 16%).
There have been no late deaths over a median follow-
up period of 6.5 years (range, 2 months–18 years) with
a total of 145 patient-years of follow-up.
Currently, 18 patients have normal clinical exercise
ability (NYHA class I). Three patients are mildly
symptomatic (NYHA class II) with tachypnea on exer-
tion as the main symptom. One of these children, now
2 years old, who underwent circumflex ligation at 6
weeks of age, has moderate to severe mitral regurgita-
tion and requires continued medical therapy, although
LV function was nearly normal on a contrast left ven-
triculogram and the radionuclide LVEF was 59% at
rest. The second infant, now aged 2 years, who under-
went coronary implantation at 10 months of age, has
occlusion of the implanted left main coronary artery on
angiography with collateral flow from the right coro-
nary artery (“ligation equivalent”) and also requires
continued medical therapy.
Three patients are being treated with angiotensin-con-
verting enzyme inhibitors (including the 2 patients just
described); 2 patients with mechanical valves require
warfarin therapy, and 2 patients are being treated with
aspirin. No patient requires diuretics or digoxin therapy.
Since 1989, 5 of 12 patients undergoing an operation
have received LVAD support when there has been sig-
nificant difficulty in weaning from cardiopulmonary
bypass. The mean preoperative fractional shortening in
the 5 patients was 12.4% (SD, 1.7%). Support was
required for a median of 3 days (range, 2-4 days), and
there has usually been significant clinical improvement
in cardiac function observed during this period, as mea-
sured by inotropic drug requirement. Two patients in
this group had neurologic deficits, with full recovery in
one patient. No other patient in the series had a neuro-
logic deficit.
Two patients underwent subsequent procedures, one
procedure for mitral valve replacement at 19 months
after the initial operation and the other procedure for
the repair of pulmonary artery stenosis at 7 years after
a Takeuchi repair. This provides an 84% freedom from
reoperation at 10 years (95% CI, 47% and 96%; Fig 3).
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Exercise capacity. In the 8 patients who underwent
testing, the mean endurance was 12 minutes (SD, 1.8
minutes; range, 9.8-14.5 minutes). All performed above
the 10th percentile for their age, and 5 of the 8 per-
formed above the 50th percentile. The blood pressure
rise was normal in 7 patients; the other patient did not
have measurement at peak exercise but had a normal
blood pressure response during exercise for the radionu-
clide scan. All patients reached 90% or more of maxi-
mum predicted heart rate, with a peak heart rate of 193
beats/min (SD, 5 beats/min; range, 185-201 beats/min).
There was no chest pain or significant arrhythmia.
However, one exercise test demonstrated 2 mm of hor-
izontal ST depression, commencing at 10 minutes of
exercise. This patient has a small fistula from the intra-
pulmonary baffle to the MPA.
Late LV function. On radionuclide examination (n =
10), the mean LVEF at rest was 64% (SD, 8%; range,
50%-73%; normal laboratory reference range, 50%-
70%). In the 7 patients who were old enough to per-
form semisupine exercise, the LVEF rose significantly
from 66% (SD, 9%) to 76% (SD, 8%; 95% CI for the
difference, 6% and 14%; P = .001), with the heart rate
increasing from 78 (SD, 8) to 148 (SD, 15) beats/min.
There were no wall motion defects observed on
radionuclide study, except in the infant who had
required infarct resection and LV repair and who had
reduced anteroseptal wall motion, but this patient’s
global LVEF was within the normal range at 64%. The
mean first-pass right ventricular ejection fraction was
65% (SD, 6%; range, 57%-76%; laboratory normal ref-
erence range, 45%-65%).
The most recent echocardiographic examination (n =
18) included 2 patients without dual coronary revascu-
larization. Three patients had significantly abnormal
ventricular septal motion. In these 3 patients, the LV
posterior wall contractility was described as normal in
2 of the patients and reasonable in the patient with an
occluded left main coronary repair. In the other 15
patients, the mean LV shortening fraction was 34%
(SD, 4%; range, 30%-40%). However, mildly flattened
ventricular septal motion in 5 of these patients may
have reduced the calculated shortening fraction. The
shortening fraction was normal for age in 9 of the
remaining 10 patients and mildly reduced (30% at 13
months of age) in 1 patient with at least moderate
mitral regurgitation. LVEDD was normal for body sur-
face area in 12 patients and increased in 5 patients, 3 of
whom had at least moderate mitral regurgitation.
Increased echogenicity of the papillary muscles and
LV endocardium was noted in 10 of 18 patients, con-
sistent with old ischemic injury and fibrosis.
Two patients, after Takeuchi repair, have baffle leaks
into the MPA. One of these patients had ST segment
changes on exercise testing and achieved 14.5 minutes
on the treadmill. Four other patients who had baffle
procedures, including the patient who underwent late
repair of the MPA, have a mildly increased peak sys-
tolic flow velocity (1.9-2.4 m/s) in the MPA on echo-
cardiography. One patient has mild pulmonary valve
stenosis.
Time course of LV recovery. The mean preoperative
fractional shortening (n = 15) was 19.6% (SD, 9.3%).
At 1 week after the operation (n = 10), it remained sim-
ilar at 20.8% (SD, 9.0%; P > .20). There was a signifi-
cant improvement by 1 to 6 months after the operation
(n = 18) to 28.4% (SD, 10.3%; mean difference, 8.8%;
95% CI for the difference, 1.6% and 16.0%; P = .02)
Fig 3. Kaplan-Meier analysis for freedom from reoperation after repair of anomalous left coronary artery, with
the 95% confidence limits included.
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and marked recovery by 1 year after repair (n = 14) to
32.8% (SD, 5.9%; mean difference, 13.3%; 95% CI for
the difference, 7.0% and 20%; P < .001). At late fol-
low-up (all measurements >2 years from the operation;
n = 34) the recovery was maintained (P < .001, com-
pared with preoperative level; Fig 4). The proportion
with an abnormal shortening fraction fell from 80%
before the operation to 9% at 1 year.
The changes in LVEDD were analyzed in a similar
fashion to fractional shortening (Fig 5). The LVEDD
before the operation (n = 12) was markedly enlarged
for a predominantly infant population at 48.3 mm (SD,
5.8 mm). It fell rapidly within the first week of the
operation (n = 10) to 37.3 mm (SD, 6.2 mm; mean dif-
ference, 11 mm; 95% CI for the difference, 7 mm and
15 mm; P < .001) and was significantly less at all sub-
sequent time points (P < .001, at 1 to 6 months [n = 16];
at 1 year [n = 13]; and P = .01 at late follow-up [n = 35]
compared with preoperation). The maximal fall
occurred at 1 year after the operation to 35.1 mm (SD,
5.2 mm; mean difference, 13.2 mm; 95% CI for the dif-
ference, 8 mm and 18 mm). The modest increase
between 1 year and late follow-up (range, 2-16 years)
reflects the normal cardiac growth in these children.
Late mitral valve regurgitation. Among the 21
patients, 3 patients have undergone mitral valve surgery.
Of the 18 patients with available recent echocardio-
graphic results, 5 patients have at least moderate mitral
regurgitation (including the 2 patients without revascu-
larization); 9 patients have trivial to mild regurgitation;
2 patients have no mitral regurgitation, and 2 patients
have a mitral prosthesis. The severity of regurgitation
immediately before the operation and on the latest fol-
low-up echocardiogram were compared. Nine of 16
(56%) patients with a dual coronary repair had a reduc-
tion in regurgitation of 1 grade or more at late follow-
up, although 44% had minimal or no improvement.
Discussion
This study demonstrates that excellent early and late
survival can be obtained with current operations. The
late clinical status is generally good; with all except 3
patients in NYHA class I, all children tested were able
to achieve a normal level of exercise and there was
good recovery of LV function. However, the important
residual problem in at least one third of patients has
been significant mitral regurgitation.
Surgical technique. Our approach, like that of other
groups, has evolved over the time of this experience,
aided by increasing confidence in coronary transfer
from the arterial switch procedure. We currently regard
direct aortic implantation of the anomalous artery as
the preferred technique, and there are several methods
described for lengthening of the coronary pedicle.11,17,18
However, our late results suggest no difference in the
outcome between aortic implantation and the intrapul-
monary baffle. By the use of a large pericardial patch to
the anterior wall of the MPA with the baffle repair, the
incidence of pulmonary artery stenosis has been low
compared with that in some other series.19
LV function. The late results indicate nearly com-
plete recovery of LV function, despite severe impair-
ment at initial examination, confirming previous
work.19-21 This recovery begins in the first few days
after the operation, demonstrated by the rapid recovery
in infants requiring LVAD support, and is usually com-
Fig 4. Time-related changes in LV fractional shortening percentage, before the operation (n = 15), at 1 week (n =
10), at 1 to 6 months (n = 18), at 1 year (n = 14), and beyond 2 years (n = 34). *P < .05; **P < .01; ***P < .001.
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plete by 1 year after the operation. This capacity for
rapid recovery is an excellent example of myocardial
hibernation.21
However, mild, but persisting, ventricular enlarge-
ment is seen in several patients, sometimes but not
always explained by mitral regurgitation; and abnor-
malities of ventricular septal motion are also common,
indicating residual effects of the ischemic insult. This
is consistent with pathologic studies demonstrating
widespread but patchy endocardial fibrosis despite
revascularization.23
This study demonstrates that the first sign of the
recovery in LV function is a rapid reduction in cardiac
size, measured as LVEDD, within 1 week of the oper-
ation, even though the fractional shortening has not
changed at that stage. Subsequently, the fractional
shortening progressively recovers over 1 year, similar
to the time course reported by others.19,20
Mitral regurgitation is an almost universal feature at
presentation, because of a combination of papillary
muscle ischemia or infarction and subsequent fibrosis,
LV free wall dyskinesis, and LV dilation. Our policy is
to not repair the valve at the time of coronary repair,
because this increases the cardiac ischemic time, and
improvement usually occurs after recovery of LV func-
tion. This improvement is slower than the changes seen
in cardiac size and contractility. Furthermore, adult car-
diac experience has demonstrated the difficulty often
found in achieving major improvement for “ischemic
mitral regurgitation” by valve repair.
However, significant mitral regurgitation persists in
at least one third of patients, despite good recovery of
LV function. This usually reflects the presence of irre-
versible papillary muscle infarction and scarring.
Therefore, in an older child undergoing a primary
operation for ALCAPA with established mitral regurgi-
tation, concomitant valve repair is warranted.
Study limitations. The presence of mitral regurgita-
tion limits the accurate assessment of LV function, in
particular on the radionuclide examination, because it
overestimates the LVEF percent. However, the normal
response to exercise on the radionuclide study and the
normal exercise duration in these children suggest that
the level of cardiac function is quite satisfactory.
The grading of mitral regurgitation by Doppler
echocardiography is often qualitative and at best semi-
quantitative. The degree of mitral regurgitation at earli-
er times in this study was determined from echocardio-
grams reported by a number of observers, although the
most recent echocardiograms in the investigational
subgroup (n = 10) were performed by one observer
(D.M.C.). Given the time period of the study (18
years), developments in 2-dimensional and Doppler
echocardiography over this period, and the geographic
dispersion of the patients, the evaluation of mitral
regurgitation may have varied because of different
grading techniques and observers.
Abnormal ventricular septal motion may cause diffi-
culty with interpretation of the LV fractional shorten-
ing, and we acknowledge that, in the assessment of
time-related changes, we have taken no account of this
abnormality. However, the presence of abnormal septal
Fig 5. Time-related changes in LVEDD, before surgery (n = 12), at 1 week (n = 10), at 1 to 6 months (n = 16),
at 1 year (n = 13), and beyond 2 years (n = 35). *P < .05; **P < .01, ***P < .001.
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motion would reduce the measured fractional shorten-
ing and therefore should not alter the broad conclusion.
For the study of time-related changes in LV function,
our analysis attempted to account for the problem of
“missing data.” Fifteen patients had satisfactory preop-
erative measurements, but the number and timing of the
postoperative studies varied between patients, with a
total of 91 studies in the group at different times. The
presence of missing data was greater in the earlier
patients and in patients referred from distant centers.
The analysis assumes that the data are missing at ran-
dom. The alternative explanation would be that there is
a bias and that the sicker patients with poorer postoper-
ative function may have had closer follow-up and more
studies. However, although this may change the magni-
tude of the improvement observed, it would not alter
the basic conclusion that even infants with severely
impaired LV function will usually show a dramatic
recovery of LV function.
Experience with a single coronary circulation.
Coronary ligation was performed in one patient with
isolated origin of the circumflex artery. In retrospect,
this infant may have done better with revasculariza-
tion. The circumflex territory initially appeared quite
small on angiography, but subsequent angiography at 2
years of age suggests that it is a dominant artery sup-
plying the whole of the inferior and lateral LV walls
and that the initial appearance may have simply re-
flected the poor collateralization, which resulted in
early onset of symptoms. The very early onset of symp-
toms at 6 weeks of age with heart failure and mitral
regurgitation also suggests that the circumflex artery
was serving a significant portion of the myocardium.
The continuing symptoms and mitral regurgitation in
the child with an occluded repair (“ligation equiva-
lent”) add further evidence for the benefit of revascu-
larization over ligation.
LVAD support. This has become an important
adjunct to pediatric cardiac operations.24 Infants with
ALCAPA provide one of the ideal groups for LVAD
use, because there is predominant LV dysfunction, often
transiently exacerbated by the operation (“myocardial
stunning”) and subsequent rapid improvement in LV
function. This favorable experience in patients with
ALCAPA has also been reported by other centers.20
Place of heart transplantation. Some authors have
performed heart transplantation for infants with this
lesion and severely impaired LV function.25,26 Our
experience, and that of others,20 would suggest that
there is little indication for transplantation as the pri-
mary surgical treatment. Even when LVAD support is
required, late cardiac function has been good.
We thank the cardiologists in other states of Australia who
provided follow-up information: Dr Jim Ramsay and Dr
Luigi d’Orsogna (Perth), Dr Brodie Knight and Dr Malcolm
Richardson (Adelaide), and Dr Chris Whight (Brisbane).
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Discussion
Dr Yasuharu Imai (Shinjuku-ku, Japan). I would like to
congratulate Dr Cochrane and his colleagues for their excel-
lent results. There were no operative deaths and no late deaths
in their series of 21 patients, and the importance of LVAD
support in 5 high-risk infants is emphasized. 
Our surgical experience in ALCAPA comprised 29 cases in
the past 17 years, and we also intended to establish a 2-coro-
nary system in all cases using direct aortic implantation in 18
cases and Takeuchi operation in 11 cases. I find that the best
advantage of the Takeuchi procedure is coronary rerouting in
situ, when there is no redundancy in the left coronary artery
in infancy. Therefore, if there is any doubt, we prefer to do
Takeuchi procedure in infants. 
A major difference arises in the concomitant mitral repair.
In our series of 29 cases, 23 infants had a significant mitral
regurgitation, ranging from moderate to severe, so we did
mitral annuloplasty at the anterior commissure in 23 patients
concomitantly with the repair of the coronary artery. As you
know, the mechanism of mitral regurgitation in this subset
was infarction or ischemic elongation of the anterior papillary
muscle and its chordae, which caused the prolapse in the
region of anterolateral commissure. These pathological
changes in supportive structure did not seem to improve sig-
nificantly with time. Standard Kay-Reed–type annuloplasty
at the anterior commissure was quite effective to reduce
regurgitation even in the immediate postoperative period.
Therefore in our series there is not much of the significant
regurgitation remaining in the postoperative period. 
Regarding LV function, I agree completely with Dr
Cochrane. Within several years, LV function became normal-
ized, in our case 62% in average, ranging from 55% to 67%.
LV end-diastolic volume decreased also markedly an average
of 126% of normal, ranging from 101% to 145%. 
What is your criterion of concomitant mitral repair,
because only 2 patients had mitral valve replacement or
repair at the time of operation? 
What is your practical management of LVAD including
anesthetic agent, vasodilator, phenoxybenzamine, optimal
blood flow, ultrafiltration unit, if you have optimal blood
pressure to be maintained, and criteria for weaning? 
Were there are any differences in the ischemic times in direct
aortic implantation and Takeuchi operation in your series? 
Dr Cochrane. You mentioned first that you prefer to use
the intrapulmonary baffle, and I think we would have no
major disagreement with that. That obviously has been the
major technique of repair, although more recently we have
moved to aortic implantation. However, I would emphasize
that there is no difference in the long-term results between
those 2 groups. I think that, for a surgeon who is less experi-
enced and is concerned about aortic implantation, the intra-
pulmonary baffle is a very appropriate operation. However,
because we have had increasing experience with the arterial
switch and with mobilization of coronaries, we have become
more comfortable with the reimplantation. 
In terms of the crossclamp times, the ischemic times, they
are rather longer with aortic implantation, and I think that is
one factor that has to be considered, particularly if LV func-
tion is very poor. The mean crossclamp time in the Takeuchi
intrapulmonary baffle procedure is about 42 minutes and for
aortic implantation about 55 minutes. 
With regard to LVAD, there were 5 patients. Their median
age was 5 months, so it was the younger infants. They had
particularly poor preoperative fractional shortening, mean of
12%. Support was required for a median of 3 days, ranging
from 2 to 4 days. Two patients had neurologic complications
with good resolution in one patient, but persisting hemipare-
sis in one other patient. 
We looked at the risk factors for LVAD use, looking at age,
degree of mitral regurgitation, fractional shortening, and dias-
tolic dimension. Although none of these are significant,
because the numbers are inadequate, I would emphasize that
there does appear to be a trend toward increased risk of LVAD
use in patients with larger ventricles and poorer fractional
shortening. The Z score in the 5 patients with LVAD was 9.6,
nine standard deviations away from the mean, compared with
5.7 in the patients without LVAD with a high odds ratio but
very wide confidence limits because the numbers are small
and similarly, for fractional shortening, 12% in the patients
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with LVAD compared with 19%. Again I would emphasize
that the numbers are inadequate, but there are some trends. 
With regard to the LVAD management, I think I can ad-
dress all of those issues. We do not routinely use dilators, but
we use them as appropriate according to the mean perfusion
pressure. We would aim to run a mean arterial pressure
around 40 to 50 in most infants on LV assist support. We
would run full flow, which for us means 150 mL/kg per
minute. In general, recovery of function, as I have shown, is
fairly quick. We would expect to see ejection by the second or
certainly the third day after the operation. We would then
wean to a low flow in the intensive care unit on a small dose
of dopamine and assess function clinically and on echocar-
diography, using transesophageal echocardiography if neces-
sary, and would then, if the findings appeared satisfactory,
return to the operating theater for decannulation. 
Finally, in terms of the place of mitral valve operations,
we have not performed mitral valve operations initially, and
we believe that the most important thing is revasculariza-
tion to allow recovery of myocardium. The reasons that we
do not perform repair in the infant group follow: First, in
two thirds, it is not necessary. It means a longer crossclamp
time in a damaged heart in those patients. We believe that
the mitral operation is certainly easier technically at a later
time in childhood when annuloplasty rings can be used
along with other procedures, which are significantly more
difficult in the infant group where one is restricted more or
less to a commissural annuloplasty. We know from adult
experience that ischemic mitral regurgitation can be diffi-
cult to repair, certainly to get complete repair. However, I
would agree that in an older child, above 2 years of age, if
there is significant mitral regurgitation, that mitral repair at
the time of operation is very reasonable and that we proba-
bly would do that.
Mr Magdi Yacoub (London, England). In your series, you
have used a variety of techniques for revascularization. Have
you looked at anatomic or functional characterization of
either the proximal or distal coronary circulation associated
with each technique? We have used a method of anatomic
correction of the anomaly by threading the button behind the
pulmonary artery, implanting it from inside the aorta in the
middle of the left coronary sinus, and we think that has func-
tional implications. Have you looked at either anatomic or
functional characteristics of the coronary circulation in the
different techniques?
Dr Cochrane. I think I can partly answer the question.
Quite a number of these patients have had angiography at a
later time. And anatomically, in all cases, there appears to be
a wide open ostium and no obvious difference. 
In terms of function, we have said that LV function is nor-
mal; but in terms of coronary endothelial function, I do not
think I can make any comment if that is the aspect you are
referring to. 
Mr Yacoub. And the site of implantation, do you think that
is important whether it is in the sinus or not? 
Dr Cochrane. I do not think that the site of implantation
into the aorta is particularly important. I think, in most cases,
that it really depends on what appears to be anatomically the
most appropriate site. 
Dr Vladimir Alexi-Meskishvili (Berlin, Germany). In our
group in Berlin, we had the opportunity in the last 7 years to
treat 23 patients with this anomaly. Among them were 18
children and infants; the youngest was 3 weeks old. In all
patients we prefer to perform direct implantation of the coro-
nary artery. But contrary to your group, we prefer to correct
mitral incompetence during the implantation because we
think that correcting the mitral incompetence provides better
cardiac output after the operation. None of our patients need-
ed mitral valve surgery later on during follow-up.
Do you consider, in the future, reconstruction of the mitral
valve in patients with severe mitral incompetence and
enlarged left atrium, which is sometimes seen by patients
with this anomaly? 
We, too, successfully used the LVAD in our patients in 3
cases, and I am interested in your indication for this kind of
assist. Do you use long reperfusion after the unsuccessful
attempt to wean patients from the heart-lung bypass or how
do you make the decision to use an assist device in your
patients with this anomaly? 
Dr Cochrane. With regard to the place of mitral valve
repair, you report excellent results from early concomitant
mitral valve repair, and it is difficult to comment because we
have had a different philosophy. I can only emphasize that
two thirds of patients have done well with significant im-
provement and would not have needed valve repair; however,
I recognize that there are different philosophies and methods
of management. 
In terms of the indications for LV assist support, clearly
there have been a number of surgeons involved over a period
of time, so that we do not have rigid criteria. In most cases,
there would have been a significant period of reperfusion after
removal of the crossclamp, and there might well have been
several attempts at weaning from bypass. The usual indica-
tions would be inability to wean, having had 1 or 2 attempts to
wean from bypass, and excessively high inotropic require-
ment, by which I mean that we were needing a very high dose
of dopamine or that epinephrine had been necessary to insti-
tute. We believe that, rather than causing further damage to
these hearts with excessive doses of epinephrine, it is much
better for recovery of the heart to place the patient on LV
assist. Usually it is necessary for a median of only 3 days.
Dr Zohair Y. Al-Halees (Riyadh, Saudi Arabia). We also
have had gratifying results in 10 patients with the same
anomaly that we corrected at our institution. In all of the
patients, a 2-coronary artery system was established. Though
our follow-up is not as long as yours and is a maximum of
about 9 years, we observed improvement in all of the
patients. The mean ejection fraction improved from 35% to
57% (fractional shortening, 19%–31%). However, we noticed
that the ventricles that were poorer to start with showed less
recovery. We also analyzed the electrocardiograms in all
patients. We observed ischemic changes preoperatively in the
form of abnormal Q waves in leads I, aVL, V4-V6, with ST
segment depression of more than 0.1 mm. There was evi-
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dence of left axis deviation for age in 5 patients and LV
hypertrophy in 8 patients. These changes normalized postop-
eratively, particularly the signs of ischemia.
Did you notice, what we observed, that poorer ventricles
tend to show less recovery? Have you looked at the electro-
cardiograms of the patients and noticed similar changes to the
ones we described?
Dr Cochrane. With regard to the electrocardiogram, yes, I
think that the changes are similar and that they have been
widely reported before. The electrocardiogram improves
quite markedly, and in the long term there may be only min-
imal residual changes. So yes, I would certainly agree with
those findings, but they have been reported extensively
before.
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